tirzepatide triple agonist Retatrutide vs Tirzepatide: Key Differences Explained – C2 Peptides The Tirzepatide Revolution: Is Dual
Description
Patients who experience intolerable side effects at any dose can remain at their current level longer before titrating upward
Treatment decisions and prescribing practices are made based on the independent medical judgment of the provider's care team
What does all this discussion mean
The dual GLP-1/GIP activation suppresses hunger signals, slows digestion, and creates powerful satiety
doi:10.1002/dmrr.553 12
Retatrutide is currently in Phase 3 clinical trials, with study completion expected in 2025
